Q/C TECHNOLOGIES, INC.
For the period ended Dec 31, 2025. Filed Apr 15, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Apr 15, 2026
QCLS$0.37+8.8%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Operations
| For the Years Ended December 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Product Revenue · $ · - · $ · - | ||
| Product Cost of Sales | - | - |
| Gross Income | - | - |
| Administrative Expenses | 3,736,525 | 4,161,907 |
| Research and Development Expenses | 3,471,841 | 3,441,010 |
| Stock Based Compensation | 2,174,524 | 1,057,271 |
| Franchise Tax Expense | 200,050 | - |
| Series F-1 Warrant Issuance Expenses | - | 539,097 |
| Series G Warrant Issuance Expenses | - | 969,505 |
| Series H Warrant Issuance Expenses | 264,417 | - |
| Loss from Operations | (9,847,357) | (10,168,790) |
| Other (Income) Expenses | ||
| Interest and Dividend Income | (225,388) | (351,809) |
| Gain on Sales of Marketable Securities | (2,176) | (976) |
| Unrealized Gain on Marketable Securities | (38,671) | (671) |
| Impairment on Equity Investment | 1,500,000 | - |
| Change in fair value of Derivatives Liabilities | (983,000) | 388,000 |
| Change in fair value of Contingent Consideration | 1,529,000 | |
| Change in fair value of Warrant Liabilities | - | 4,410,000 |
| Loss on issuance of Series F-1 Convertible Preferred Stock | - | 3,737,000 |
| Loss on issuance of Series G Convertible Preferred Stock | - | 5,109,000 |
| Casualty Loss/(Gain) | - | (100,000) |
| Total Other (Income) Expenses | 1,779,765 | 13,190,544 |
| Loss Before Income Taxes | (11,627,122) | (23,359,334) |
| Income Taxes | - | - |
| Net Loss | $(11,627,122) | $(23,359,334) |
| Preferred Stock Dividends | 3,357,324 | 3,801,885 |
| Net Loss Attributable to Common Stockholders | $(14,984,446) | $(27,161,219) |
| Basic and Dilutive net loss per common share | $(8.66) | $(1,080.87) |
| Weighted average basic and diluted common shares outstanding | 1,729,946 | 25,129 |
The accompanying notes are an integral part to these consolidated financial statements.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.